Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 22)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CARDIOME PHARMA CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for CRME: the economy's impact on CRME's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CARDIOME PHARMA CORP 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CARDIOME PHARMA CORP 5 $25 View Abstract
18-Jan-10 Zacks Investment Research Inc. N/A CARDIOME PHARMA (CRME) Zacks Company Snapshot 1 $10 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CARDIOME PHARMA CORP 5 $25 View Abstract
11-Jan-10 Zacks Investment Research Inc. N/A CARDIOME PHARMA (CRME) Zacks Company Snapshot 1 $10 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct Cardiome Pharma Corp Financial and Strategic Analysis Review 22 $300 View Abstract
Next 12

Independent Reports (Showing 1 to 10 of 22)

Release
Date Contributor Author Title Pages Price More Info
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CARDIOME PHARMA CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for CRME: the economy's impact on CRME's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CARDIOME PHARMA CORP 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CARDIOME PHARMA CORP 5 $25 View Abstract
18-Jan-10 Zacks Investment Research Inc. N/A CARDIOME PHARMA (CRME) Zacks Company Snapshot 1 $10 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CARDIOME PHARMA CORP 5 $25 View Abstract
11-Jan-10 Zacks Investment Research Inc. N/A CARDIOME PHARMA (CRME) Zacks Company Snapshot 1 $10 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct Cardiome Pharma Corp Financial and Strategic Analysis Review 22 $300 View Abstract
Next 12

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.